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Introduction
Respiratory diseases remain one of the main causes of morbidity and mortality in the world. Interest has increased as to the possibility of optimizing the repair of the lung with the use of stem cells (SCs). In particular, combining SC ability to engraft into damaged lungs and their ability to serve as carriers of a therapeutic gene has a great potential for pulmonary fibrosis ( ) and for genetic airway disease such as cystic fibrosis. This developing therapeutic approach has been stimulated by early reports demonstrating that both embryonic stem cells and SCs derived from adult bone marrow, including mesenchymal stem cells, can differentiate into respiratory cells In most of these studies, systemic administration of SCs required total-body irradiation of the recipient to promote SC bone marrow engraftment, a difficult condition to apply in the clinical setting, especially in patients suffering from airway disease associated with chronic infections such as cystic fibrosis. Alternatively, considering the advantages of the intratracheal route to target the airway and the respiratory epithelium, more recent studies reported the intratracheal administration of adult SCs in reagent-injured lungs (Gupta et al., ; ). Using fluorescent techniques SC engraftment was enhanced with the intratracheal route as compared to the 2007 The aims of our study were to evaluate the survival and the engraftment of different types of exogenous SCs and differentiated cells after intratracheal injection. We used a murine model presenting acute epithelial airway injury without total-body irradiation. This model was developed for gene therapy experiments on cystic fibrosis and consisted in intranasal injection of polidocanol detergent (Parsons et al., ). Quantification of cell survival rates and cell location within lungs were performed using ELISA, biochemical assay and PCR. 1998
Materials and methods

Animal model and intratracheal administration
Male, 8-to 10-week old Swiss mice were obtained from Janvier Laboratories (Le Genest St Isle, France). Animal experiments were performed under the approval of the published by the U.S. National Institutes of Guide for The Care and Use of Laboratory Animals Health (NIH Publication No. 85-23, revised 1996) . Mice were anesthetized with an intraperitoneal injection of xylazine (15mg/kg) and ketamine (70mg/kg), and placed supine. Briefly, intratracheal administration was performed using a 22-gauge catheter placed within an intubation canula (Harvard Apparatus) that was removed immediately before injection. Airway injury was induced after anaesthesia by intratracheal administration of 25 l of 2 polidocanol (PDOC: polyoxyethylene 9-lauryl ether, Sigma, ( ; μ intratracheally injected 24hr after PDOC administration using the same protocol. Mice were sacrificed by an intraperitoneal lethal injection of nesdonal 24hr or 7 days after intratracheal administration.
Bronchoalveolar lavages
Bronchoalveolar lavages (BALs) were performed 24hr after CAT-transfected cell administration in healthy or injured airway. Mice were anesthetized and thoracic cavity was opened by careful dissection. The trachea was exposed, and a small transverse incision performed just below the level of the larynx. BAL was then performed using one dose of 1 ml of PBS, ensuring that both lungs inflated during the lavage process and that there was no leakage of lavage fluid from the trachea. BAL fluid was centrifuged at 400 g for 5 min.
The supernatant was removed and stored at 80 C until ELISA. Cell pellet was suspended in lysis buffer and stored at 80 C until ELISA. Undifferentiated murine mesenchymal stem cells (BMC9s, ( )) were cultured as previously described ( Dennis and Caplan 1996 ) in alpha MEM medium with nucleosides (Invitrogen) supplemented with 10 FCS (Invitrogen), 2mM Chateauvieux 2007 et al., % L-Glutamine (Invitrogen), penicillin/streptomycin (100U/ml and 100 g/ml respectively, Invitrogen). control experiments. Cells were cultured in DMEM medium with 4.5 g/l glucose supplemented with 15 FCS, 2 mM L-Glutamine, % penicillin/streptomycin (100U/ml and 100 g/ml respectively). Total bone marrow was obtained from wild type adult male Swiss mice and male Rosa26 lacZ-mice (background C57Bl/6J x 129S2, kindly provided by Dr M.F. Gardahaut, Nantes, France) by flushing femurs and tibias with culture medium. Cells were plated at a density of 500 000 cells/cm in medium composed of alpha MEM with nucleosides supplemented with 10 FCS, 2 mM L-Glutamine, 2 % penicillin/streptomycin (100U/ml and 100 g/ml respectively) and 2ng/ml of human FGF2 (AbCys). The culture medium was changed at μ day 3 to remove non-adherent cells and was subsequently replaced weekly. The cells were grown for 2 3 weeks until confluence. In vitro cell transfection with CAT or GFP reporter genes and evaluation of gene transfer system efficacy ESCs, BMC9s and differentiated cells were transfected with pCIK-CAT (4.7 Kb) and pEGFP-C1 (4.7 Kb) plasmids encoding for Chloramphenicol AcetylTransferase (CAT) protein and GFP, using synthetic vectors just prior to intratracheal administration (Pitard et al., ) . DNA plasmids were complexed with ICAfectin 441 according to the manufacturer s instruction (In-Cell-Art, Nantes, France). 2001
After 2hr, transfection complexes were removed by changing growth medium and cells were lysed for dosages or kept in culture for 24hr, 7 days, or injected intratracheally as indicated above.
MSCs from Swiss mice were transfected with pCIK-CAT and pEGFP-C1 plasmids using nucleofection (Nucleofector Solution, Amaxa Biosystem) just prior to intratracheal administration ( ). After 2hr, growth medium was changed and cells were Aluigi 2006 et al., lysed for dosages or kept in culture for 24hr, 7 days, or injected intratracheally as indicated above. The percentage of GFP-expressing cells was evaluated 24hr after GFP nucleofection using FACS analysis.
The efficacy of gene transfer systems was evaluated using cytometry for GFP-expressing cells and ELISA for CAT-expressing cells.
The percentage of GFP-expressing cells was evaluated 24hr after GFP transfection using FACS analysis (FACS Calibur Instrument, BD Biosciences, CellQuestPro Software). CAT protein quantity per stem cell at 24hr was then calculated using data: CAT protein in vitro quantity in cell lysis buffer was divided by the cell number and by the percentage of GFP-expressing cells (obtained by FACS analysis).
Finally, this value was used to determine the minimum number of CAT-expressing stem cells required to be detected by ELISA or in vitro considering that CAT ELISA detection threshold was 50pg CAT protein (see below). To estimate cell survival rate 24hr after intratracheal administration, we first calculated CAT protein quantity per CAT-expressing cell, using data: CAT quantity in cell lysis buffer was divided by the cell number and by the percentage of GFP-expressing cells in vitro (obtained by FACS analysis). Finally, the total CAT protein quantity per animal was divided by this value, in order to in vivo in vitro estimate the number of CAT-expressing cells per animal and subsequently the cell survival rate.
BMC9s and Rosa26 MSCs or whole frozen murine trachea-lungs were homogenized in 1ml reporter lysis buffer (Roche Diagnostics) supplemented with a protease inhibitor cocktail (Roche Diagnostics). After centrifugation at 10 000 rpm for 5min, gal activity was 
Detection of nls-lacZ reporter gene
Total DNA from whole murine trachea-lungs was isolated for PCR analysis. Tissues were digested overnight with lysis buffer containing proteinase K (10mg/ml, Sigma). Total DNA was extracted with phenol/chloroform/isoamyl alcohol (Sigma) method and then precipitated in ethanol. Total DNA from 10 transduced MSCs was also extracted for PCR experiments. PCR were performed using 6 primers that specifically bind the nls sequence and the lacZ gene encoded in the nls-lacZ lentivirus vector: 5 -GTA ACA ACT CCG CCC ′ CAT T -3 and 5 -GAC AGT ATC GGC CTC AGG AA -3 .
Statistical analysis
Data are expressed as means S.E.M. Statistical significance was evaluated using the analysis of variance (ANOVA) method to ± compare control and treatment groups of 3 or more. Tukey s test was subsequently used for pair-wise comparisons. A non parametric
'
Mann and Whitney test was performed to compare two groups. Statistical significance was set at p<0.05.
Results
Transient epithelial airway injury induced by polidocanol intratracheal administration
Intratracheal administration of 2 PDOC induced macroscopic lung injury at 24hr with haemorrhage ( with plasmids encoding CAT or GFP reporter genes 2hr prior to intratracheal injection. CAT-transfected stem cells in vitro were then intratracheally injected, at a time where they did not yet express the foreign genes (see below). We hypothesized that only surviving stem cells would express CAT protein in trachea-lungs 24hr after intratracheal cell injection. in vivo Two hours after the beginning of cell incubation with both plasmids and synthetic vectors, transfection complexes were removed and reporter gene expression was evaluated. Neither CAT protein nor cell fluorescence was detected in stem cells using ELISA ( ) and Fig. 2b microscopy (not shown), demonstrating that stem cells did not express CAT nor GFP protein at the time of injection. in vivo
In vitro reporter gene expression was also evaluated 24hr and 7 days after incubation with plasmids and synthetic vectors. As evaluated by FACS analysis, 19.4 0.2 ESCs (n 6) and 37.0 4.4 BMC9s (n 6) expressed GFP at 24hr ( ). However, CAT and GFP
were not detected at 7 days after transfection ( ), suggesting that transgene expression was transient. Using CAT ELISA quantitative Fig. 2b results and GFP-expressing cell rates, we calculated that CAT-expressing ESCs and CAT-expressing BMC9s contained at 24hr 0.03 ± 0.01pgCAT/cell (n 10) and 0.08 0.02pgCAT/cell (n 6), respectively. Cell values were further used to evaluate the number of only stem cells survived after intratracheal injection in injured airway. CAT-transfected ESCs and BMC9s were injected in control healthy animals. No CAT protein was detected in any animal with healthy airway 24hr after stem cell injection ( ), suggesting that stem cell Fig. 2c survival was favoured by airway injury.
Cell survival in the epithelial lining fluid
To evaluate whether cells expressing CAT reporter protein were present within the epithelial lining fluid or after phagocytosis by alveolar macrophages, bronchoalveolar lavages (BALs) were performed at 24hr in conditions when phagocytosis was expected in vivo maximal, e.g. when CAT ELISA results were negative: mesenchymal stem cells (BMC9s) in healthy airway and murine differentiated cells (mOS-J) in injured airway. As further controls, BALs were also performed in control and PDOC animals and in animals intratracheally injected with PDOC and BMC9s. No CAT protein was detected in any BAL fluid nor BAL cell sample from any animal ( ), suggesting that if stem cells or differentiated cells were phagocytosed by alveolar macrophages, such phagocytosis did not alter Fig. 2d CAT protein measurement nor cell survival detection. Importantly, in animals intratracheally injected with PDOC and BMC9s, high levels of CAT protein were measured in trachea and lung homogenates whereas no CAT protein was detected in BAL fluid nor BAL cell samples, suggesting that CAT-expressing cells were mostly present within the lungs and did not survive in the epithelial lining fluid (Fig.   ) . 2d
BMC9 location at 24hr and 7 days
Next, we investigated BMC9 location at 7 days when the airway epithelium was known to be spontaneously regenerating ( ). As CAT expression using synthetic vectors was transient, we used integrative virus vectors allowing long-term MacPherson 2005 et al., foreign gene expression. BMC9s were transduced with a retrovirus vector encoding nls-lacZ gene. As evaluated by X-Gal staining, 57.2 ± 0.1 BMC9s expressed nuclear galactosidase ( gal) when they were injected ( , n 6). gal activity in transduced BMC9s was 0.02) and remained stable at 7 days (not shown). Animals were assessed for gal activity 24hr and 7 days after intratracheal β administration, using the 4 MUG method ( ). In contrast to previous experiments, gal-transduced BMC9s expressed nlslacZ gene Fig. 3c β at the time of intratracheal injections. Therefore, as a further control, we injected lysates of gal-transduced BMC9s, and no significant β increase in gal activity was observed as compared to endogenous gal activity (Tukey s test, p 0.98). In animals intratracheally injected
with PDOC and gal-transduced BMC9s, 24hr after injection gal activity significantly increased as compared to that of control animals To locate BMC9s after intratracheal injection into injured airway, we performed X-Gal staining of trachea-lungs at 24hr and 7 in toto days ( ). No blue staining was observed in trachea-lungs ( ) and histological sections ( ) from any control animal (  Fig. 4  Fig. 4a Figs. 4b-d , n 3), animal injected with PDOC ( , n 3), or animal intratracheally injected with gal-transduced BMC9s only ( , Fig. 4a ) and injured bronchi or bronchioles ( ), but not in lung parenchyma ( ). Fig. 4k Figs. 4l,m Fig. 4l At 7 days, blue spots were observed in 7/7 animals, in the lumen of bronchioles ( ). No blue cell was observed in trachea or in Figs. 4n-p pulmonary parenchyma (not shown). Clusters of blue cells were sometimes located in polyp-like structures, located in bronchioles and large bronchi. Polyp-like structures were not observed in any animal receiving PDOC only. Further quantitative and statistical analyses demonstrated that the development of polyp-like structures at 7 days was not due to stem cell administration but rather to a second intratracheal administration (PBS or BMC9) 24hr after PDOC injection ( ). Histological analyses at high Table S2 in supplementary data magnification showed that gal-expressing cells did not have a respiratory phenotype, with no cilia at 24hr or 7 days (not shown). 
MSC survival in murine airway with acute epithelial airway injury
In a second set of experiments, to avoid cell survival linked to cell line transformation, we repeated previous experiments with in vivo the same experimental design, using murine MSCs from primary cultures. MSC cultures were characterised according to (Dominici et al., ) and 
0.2 , n 6) and CD29 , Sca-1 ( , 96.9 1.3 and 98.1 0.7 respectively, n 4) and CD106 (96 0.8 , n 4).
MSCs were transiently transfected with plasmids encoding CAT or GFP reporter genes. In contrast to ESCs and BMC9s, MSC in vitro transfection with synthetic vectors was ineffective (not shown), therefore nucleofection was used to obtain significant gene transfer rate.
As evaluated by FACS analysis, 56.8 2.9 MSCs expressed GFP at 24hr ( , n 3), but CAT and GFP were not detected 7 
MSC location at 24hr and 7 days
To investigate whether MSCs could be located into the airway epithelium 7 days after cell injection, we first used MSCs in primary cultures from gal transgenic (Rosa26) mice, thus expressing continuously cytoplasmic gal ( ). Using the 4 MUG method (
Fig. 6a Fig. 6c ), gal activity was significantly increased in Rosa26 MSCs as compared to MSCs from Swiss mice ( , Mann and in vitro β Figure 6c Whitney test, p 0.03). Mice were assessed for gal activity 24hr and 7 days after intratracheal administration of Rosa26 MSCs or of a animal injected with PDOC and gal-transduced MSCs ( , n 7), confirming that gal-transduced MSCs were present 24hr after injection in injured airway. However, no nls-lacZ gene was detected in animals at 7 days after gal-transduced MSC injection, suggesting β that no gal-transduced MSCs from primary culture survived at this time once the epithelium is regenerated ( , n 6). Another hypothesis to explain MSC negative results at 7 days is the spontaneous regeneration of the airway epithelium that may have hampered MSC incorporation into epithelial airway. At 24hr, e.g. when there is a desquamation of the epithelial surface and a denuded Stem cell therapy for respiratory disease.
Hum Gene Ther . Author manuscript Page / 8 15 basement membrane, the PDOC murine model is a good model to evaluate stem cell survival and presence in injured airway but stem cell differentiation into airway epithelial cells is unlikely at this time. At 7 days after PDOC administration, the epithelium was spontaneously regenerated, demonstrating that PDOC did not alter endogenous lung capability to regenerate. Therefore, the PDOC model may not be an adequate model to evaluate stem cell capability in regenerating lung epithelium, since the endogenous repair mechanisms may impede MSC contribution to achieve structural lung regeneration. This limitation was described in ( ) study in which the Wong 2007 et al., naphthalene-injured airway epithelium was still undergoing rapid cell turnover and regeneration and the number of administered stem cells also decreased with time. A more appropriate animal model to study stem cell contribution to structural lung regeneration would be a model with chronic epithelial airway injury and a recurrent loss of the epithelial surface, due to a lack or an exhaustion of endogenous progenitor cells. This hypothesis was evaluated in animal models with permanent retinal epithelial degeneration such as the RCS rat model (
) and the rhodopsin knock-out mouse ( 
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